Identification of differential expressed transcripts in cervical cancer of Mexican patients

Tumor Biology

Volumn 32, Issue 3, 2011, Pages 561-568

  Santos, Leticia ^a,d   León Galván, Ma Fabiola ^a   Marino Marmolejo, Erika Nahomy ^a   De La Rosa, Ana Paulina Barba ^a   De León Rodríguez, Antonio ^a   González Amaro, Roberto ^b   Guevara González, Ramón Gerardo ^c  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c DEPARTAMENTO DE INGENIERÍA QUÍMICA   (Mexico)

^d Camino A la Presa San José 2055 ^*  (Mexico)

Author keywords

Cervical cancer; Gene expression; Mexican women; SSH

Indexed keywords

COMPLEMENTARY DNA; NOTCH RECEPTOR; APOPTOSIS REGULATORY PROTEIN; CCAR1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; MYCN PROTEIN, HUMAN; NOTCH3 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; INVASIVE CARCINOMA; MEXICO; MOLECULAR CLONING; MOLECULAR DYNAMICS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION; UTERINE CERVIX CANCER; VALIDATION PROCESS; GENETIC TRANSCRIPTION; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; ISOLATION AND PURIFICATION; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

APOPTOSIS REGULATORY PROTEINS; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 16; HUMANS; MEXICO; NUCLEAR PROTEINS; ONCOGENE PROTEINS; RECEPTORS, NOTCH; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 79960598443     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0151-4     Document Type: Article

References (48)

1. Munoz N, Bosch FX, de Sanjose S, Shah KV. The role of HPV in the etiology of cervical cancer. Mutat Res. 1994;305:293-301. (Pubitemid 24082905)
2. Bosch FX, de Sanjose S. Human papillomavirus in cervical cancer. Curr Oncol Rep. 2002;4:175-83.
3. Bosch FX, de Sanjose S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers. 2007;23:213-27. (Pubitemid 47015785)
4. Bosch FX, Munoz N, Shah KV, Meheus A. Second International Workshop on the Epidemiology of Cervical Cancer and Human Papillomaviruses. Int J Cancer. 1992;52:171-3.
5. Herrero R, Brinton LA, Reeves WC, Brenes MM, de Britton RC, et al. Screening for cervical cancer in Latin America: a case-control study. Int J Epidemiol. 1992;21:1050-6. (Pubitemid 23028582)
6. Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, et al. Risk factors for invasive carcinoma of the uterine cervix in Latin America. Bull Pan Am Health Organ. 1990;24:263-83.
7. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9. (Pubitemid 29406813)
8. Min W, Wen-li M, Zhao-hui S, Ling L, Bao Z, Wen-ling Z. Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 e6 silencing rNA. Int J Gynecol Cancer. 2009;19:547-63.
9. Kim TJ, Choi JJ, Kim WY, Choi CH, Lee JW, et al. Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer. Cancer Sci. 2008;99:31-8. (Pubitemid 350239028)
10. Kendrick JE, Conner MG, Huh WK. Gene expression profiling of women with varying degrees of cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2007;11:25-8. (Pubitemid 46052190)
11. Wong YF, Cheung TH, Lo KW, Wang VW, Chan CS, et al. Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix. Cancer Lett. 2004;211:227-34. (Pubitemid 38824636)
12. de la Barba Rosa APL-MO, Briones-Cerecero EP, Chagolla-López A, De León-Rodríguez A, Santos L, et al. Analysis of human serum from women affected by cervical lesions. J Exp Ther Oncol. 2008;7:65-72. (Pubitemid 351522773)
13. Gius D, Funk MC, Chuang EY, Feng S, Huettner PC, et al. Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res. 2007;67:7113-23. (Pubitemid 47206538)
14. Unger ER, Steinau M, Rajeevan MS, Swan D, Lee DR, Vernon SD. Molecular markers for early detection of cervical neoplasia. Dis Markers. 2004;20:103-16. (Pubitemid 39149919)
15. Davelaar EM, van de Lande J, von Mensdorff-Pouilly S, Blankenstein MA, Verheijen RH, Kenemans P. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer. Tumour Biol. 2008;29:9-17. (Pubitemid 351733215)
16. Miele L. Rational targeting of notch signaling in breast cancer. Expert Rev Anticancer Ther. 2008;8:1197-201.
17. Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of notch signaling in cancer. Oncogene. 2008;27:5124-31.
18. Miele L, Miao H, Nickoloff BJ. Notch signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets. 2006;6:313-23. (Pubitemid 43961866)
19. Miele L, Rizzo P, Osipo C, Foreman K, Bocchetta M, Tonetti D. Notch as a potential therapeutic target in cancer. EJC Supplements. 2008;6:4.
20. Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene. 2003;22:6598-608. (Pubitemid 37372340)
21. Cao W, Epstein C, Liu H, DeLoughery C, Ge N, et al. Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study. BMC Genomics. 2004;5:26.
22. Burd E. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16:1-17. (Pubitemid 36114705)
23. Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, et al. Human papillomavirus type 16 e6 and e7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Cancer Res. 2000;60:4289-98. (Pubitemid 30636619)
24. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403-10.
25. Cheng Q, Lau WM, Tay SK, Chew SH, Ho TH, Hui KM. Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer. 2002;98:419-26. (Pubitemid 34189303)
26. de Wilde J, Wilting SM, Meijer CJ, van de Wiel MA, Ylstra B, et al. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer. Int J Cancer. 2008;122:877-88.
27. Gulliksen A, Karlsen F. Microchips for the diagnosis of cervical cancer. Methods Mol Biol. 2007;385:65-86.
28. Martin CM, Astbury K, McEvoy L, O'Toole S, Sheils O, O'Leary JJ. Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy. Methods Mol Biol. 2009;511:333-59.
29. Rishi AK, Zhang L, Yu Y, Jiang Y, Nautiyal J, et al. Cell cycle-and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor. J Biol Chem. 2006;281:13188-98. (Pubitemid 43855230)
30. Broggini M, Buraggi G, Brenna A, Riva L, Codegoni AM, et al. Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. Anticancer Res. 2000;20:4835-40. (Pubitemid 32127739)
31. Loffler H, Syljuasen RG, Bartkova J, Worm J, Lukas J, Bartek J. Distinct modes of deregulation of the proto-oncogenic CDC25A phosphatase in human breast cancer cell lines. Oncogene. 2003;22:8063-71. (Pubitemid 37487297)
32. Vacca A, Felli MP, Palermo R, Di Mario G, Calce A, et al. Notch3 and pre-TCR interaction unveils distinct NF-kappab pathways in T-cell development and leukemia. EMBO J. 2006;25:1000-8. (Pubitemid 43372114)
33. Bellavia D, Campese AF, Checquolo S, Balestri A, Biondi A, et al. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci USA. 2002;99:3788-93. (Pubitemid 34252184)
34. Park JT, Li M, Nakayama K, Mao TL, Davidson B, et al. Notch3 gene amplification in ovarian cancer. Cancer Res. 2006;66:6312-8.
35. Wang T, Holt CM, Xu C, Ridley C, Jones PO, et al. Notch3 activation modulates cell growth behaviour and cross-talk to Wnt/TCF signalling pathway. Cell Signal. 2007;19:2458-67. (Pubitemid 47531927)
36. Song LL, Peng Y, Yun J, Rizzo P, Chaturvedi V, et al. Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene. 2008;27:5833-44.
37. Zhang XY, DeSalle LM, Patel JH, Capobianco AJ, Yu D, et al. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci USA. 2005;102:13968-73. (Pubitemid 41377687)
38. Sun Y, Wu J, Wu SH, Thakur A, Bollig A, et al. Expression profile of microRNAs in c-MYC induced mouse mammary tumors. Breast Cancer Res Treat. 2009;118:185-96.
39. Wu CH, Sahoo D, Arvanitis C, Bradon N, Dill DL, Felsher DW. Combined analysis of murine and human microarrays and chip analysis reveals genes associated with the ability of MYC to maintain tumorigenesis. PLoS Genet. 2008;4:e1000090.
40. Subramanyam D, Krishna S. C-MYC substitutes for Notch1-CBF1 functions in cooperative transformation with papillomavirus oncogenes. Virology. 2006;347:191-8.
41. Zagouras PSS, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci USA. 1995;92:6414-8.
42. Daniel B, Rangarajan A, Mukherjee G, Vallikad E, Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol. 1997;78:1095-101. (Pubitemid 27207596)
43. Srivastava S, Ramdass B, Nagarajan S, Rehman M, Mukherjee G, Krishna S. Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression. Br J Cancer. 2010;102:196-205.
44. Talora C, Cialfi S, Segatto O, Morrone S, Kim Choi J, et al. Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways. Exp Cell Res. 2005;305:343-54. (Pubitemid 40462545)
45. Talora C, Sgroi DC, Crum CP, Dotto GP. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-e6/e7 expression and late steps of malignant transformation. Genes Dev. 2002;16:2252-63. (Pubitemid 35013088)
46. Wang L, Qin H, Chen B, Xin X, Li J, Han H. Overexpressed active Notch1 induces cell growth arrest of HeLa cervical carcinoma cells. Int J Gynecol Cancer. 2007;17:1283-92. (Pubitemid 350077350)
47. Ding LC, She L, Zheng DL, Huang QL, Wang JF, et al. Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma. Oncol Rep. 2010;24:363-8.
48. Zheng M, Zhang Z, Zhao X, Ding Y, Han H. The Notch signaling pathway in retinal dysplasia and retina vascular homeostasis. J Genet Genomics. 2010;37:573-82.